Overall, CD8 expression was higher in baseline resected tumors compared to recurrent tumors (Extended Data Fig. 6a), and there was a higher proportion of LAG-3− (<1%) tumors in recurrent tumor samples compared to baseline resected tumors (Extended Data Fig. 6a). This evidence concerns the gene CD8A and neoplasm.